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Abstract
Background: Since African-Americans have twice the prevalence of cytomegalovirus (CMV)
infections as age-matched Caucasians we sought to determine the ages and possible sources of
infection of African-American children.
Methods: Subjects were 157 African-American healthy children and adolescents and their 113
household adults in Richmond VA. Families completed a questionnaire, provided saliva for antibody
testing, and adolescents were interviewed regarding sexual activity.
Results: Regardless of age CMV seropositivity was not associated with gender, breast feeding,
health insurance, sexual activity, or household income, education, or size. In the final regression
model, prior CMV infection in adults was over two-fold higher than in children (chi-square = 18.8,
p < 0.0001). At one year of age the CMV seropositivity rate was 11% (95%CI = 4% – 24%) and
increased 1.8% each year until age 13 years. Between ages 13 and 20 years the CMV seropositivity
rate remained between 22% and 33%. For adults, the CMV seropositivity rate was 84% in 21 year
olds (95%CI = 69%–.92%). There was no association between CMV infections of the children and
their mothers but CMV infections among siblings were associated.
Conclusion: We observed that African-American children had CMV seroprevalence rates by age
20 years at less than one-half of that of their adult mothers and caregivers. Sibling-to-sibling
transmission was a likely source of CMV infections for the children. The next generation of African-
American women may be highly susceptible to a primary CMV infection during pregnancy and may
benefit from a CMV vaccine.
Background
Studies completed in the 1980s and early 1990s all found
that in the United States African-American adults have
twice the prevalence of CMV infections than have age-
matched Caucasians [1-7]. In these studies African-Amer-
icans had seropositivity rate of between 75% and 100%
[7]. In Richmond VA in the 1980s we also observed a
higher rate of CMV infections among the African-Ameri-
can population as compared to Caucasians [1]. Two stud-
ies performed at different times reported the prevalence of
CMV infections between 1986 and 1994 among African-
Americans between ages 6 and 22 years [2,4]. The rate of
CMV seropositivity increased with age and ranged from
30 to 60%. These rates were also nearly twice the rate for
age-matched Caucasians. The reasons for the increased
rate of CMV infections among African-Americans as com-
pared to Caucasians are unknown. Therefore we per-
formed a study among African-American-American
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children and adolescents to determine the possible
sources of infection.
Methods
Study population
Subjects were African-American 157 children and adoles-
cents (between 5 months and 20 years of age) and their
113 family members who were recruited from 121 fami-
lies at one private pediatric practice (106 families) and
one public pediatric practice (15 families), each of which
served inner city families in Richmond VA. The average
family size was 4.28 members (range 1 to 6). Baseline
demographics of subjects recruited from each practice
type were similar. Recruitment occurred from November,
2005 until July, 2006. Only 4 subject families declined to
participate. The index child was the one seeking medical
consultation. When two or more children were present,
the oldest child was the index child. The parent or guard-
ian of each index child provided written informed consent
for CMV testing and the completion of a demographic
questionnaire. All of the household members and siblings
present were tested for seropositivity. The questionnaire
included: household size, income level, whether the fam-
ily and/or child had health insurance, breastfeeding for
the children, and the highest level of education within the
immediate household. Index subjects greater than 11
years of age were interviewed privately by the attending
physician and a second time by one of the investigators
(I.W.) about sexual activity, birth control, and condom
use. US 2000 census data were obtained from the US Cen-
sus Bureau, Department of Commerce, Washington, DC.
Laboratory assays
Serologic status to CMV was determined using saliva. At
least 100 uL of saliva was collected in 15 mL conical tubes
by either expectoration, or for those unable to expecto-
rate, via bulb suction syringe. Saliva was stored at -20°C.
The saliva samples were assayed by enzyme immunoassay
for IgG to CMV gB as previously described [8,9]. IgG anti-
bodies to gB move passively from serum to saliva and are
present in direct proportion to their concentration in
serum [8]. The salivary assay detects IgG to gB when serum
neutralizing titers to CMV are ≥ 1:64 in the serum. Serum
neutralizing titers in seropositive sera are ≥ 1:256. To
avoid measuring maternal antibodies enrolled children
were greater than 5 months of age. Passively acquired
maternal antibody has a half life of approximately 28 days
thus by 5 months of age only 3% of maternal antibody
levels are present in an infant serum. This level would be
too low to detect in saliva [8].
Statistical analysis
Subjects are referred to as adults if they were either one of
the caregivers (four caregivers were between 19 and 21
years of age) in the family or were 21 years of age or older.
Subjects were referred to as children if they were less than
21 years of age (two children were 19 and 20 years of age).
The presence of antibodies to CMV (seropositivity) was
modeled using repeated-measures logistic regression
(GENMOD procedure in SAS version 9.1.3 SP3) with an
exchangeable correlation structure to account for within-
family correlation. The final model included the follow-
ing terms: a linear and quadratic trend for the age of the
children, a linear trend for the age of the adults, with a dif-
ferent intercept for children and adults. Likelihood-ratio
chi-square tests were used to test for significance.
This study was approved by the Virginia Commonwealth
University Institutional Review Board. Informed written
consent or assent was obtained from all subjects and stud-
ies were conducted in accordance with human experimen-
tation guidelines of the US Department of Health and
Human Services.
Results
The characteristics of the study population are listed in
Table 1. CMV seropositivity and age were determined for
157 children in 121 families. The average age of the chil-
dren was 8.37 years (standard deviation = ± 5.33 years).
For all subjects a multiple logistic regression analysis was
used to determine the p-value for the association between
each subject characteristic listed in table 1 and age and
CMV seropositivity. For children, the only characteristic
associated with CMV seropositivity was age (chi-square =
5.76, df = 2, p = 0.056), with both the linear (p = 0.023)
and quadratic trends (p = 0.042) both significant (Figure
1).
For adults age was also associated with the CMV seropos-
itivity rate (Figure 1). The average age of the 103 adults
who reported their age was 33 years (range 19 to 53 years,
SD = 8.75). Age was linearly related to CMV seropositivity
(p = 0.027) but no quadratic trend was identified (p =
0.30). After age was taken into account no other character-
istics were related to CMV seropositivity.
Of 62 adolescents, only 6 reported being sexually active.
Sexual activity was unrelated to CMV seropositivity (chi-
square = 0.05, p = 0.82). Of the six sexually active adoles-
cents each had only a single partner and condoms were
used.
For the index subjects there were 105 female (104 moth-
ers and 1 aunt) and 8 male caregivers. There was no evi-
dence for a relationship between the CMV seropositivity
rate of the index subject and the mother or the female car-
egiver (data not shown) or between the seropositivity rate
of all the children in each household and the mother or
caregiver (Table 2).BMC Infectious Diseases 2008, 8:107 http://www.biomedcentral.com/1471-2334/8/107
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For families with 2 or more children living at home, CMV
seroprevalence among siblings was associated (Table 3).
This was independent of the number or ages of the chil-
dren in the household. This within-family dependence
was taken into account in all of the primary analyses.
In the final regression model, CMV seroprevalence of
adults was higher than children (chi-square = 18.8, p <
0.0001) and for children CMV seropositivity increased
with age (Figure 1). At age one year the CMV seropositivity
rate was 11% (95%CI = 4% – 24%) and it increased
approximately 1.8% each year until approximately age 13
years. Between ages 13 years and 20 years the CMV serop-
ositivity rate remained between 22% and 33% (Table 2
and Figure 1). For younger adults, the CMV seropositivity
rate was approximately 84% (95%CI = 69%–92%) in 21
year olds (Figure 1).
Finally, we compared the data from the 2000 US census
for all African-Americans residing in Richmond, VA, the
state of Virginia and the US to our subject group. The
groups were similar for gender distribution, average
household size, education levels, and income (Table 4).
Discussion
Two novel observations emerge from this study. The first
is that the cohort of the current generation of African-
American children and adolescents in Richmond VA has
lower rates of CMV seroprevalence than the older genera-
tion comprising their parents and caretakers. We observed
a rate of CMV infections for female adults and caregivers
that averaged 70%. This rate of seropositivity is similar to
those previously reported by us for Richmond and is sim-
ilar to those reported for adults in other US cities [1-6].
Further, in a population-based survey of African-Ameri-
Table 1: Characteristics of the Study Subjects by CMV seropositivity.
No. of Children (N = 157 CMV status+ No. of Adults (N = 113) CMV status+
Characteristic Pos. Neg. Total % Pos. p-value Pos. Neg. Total % Pos. p-value
Gender 0.54 098
Male 23 58 81 28 73 32 105 70
Female 16 60 76 21 5 3 8 63
Breast fed 0.54
No 16 68 84 19
Yes 16 32 48 33
Yearly family income 0.66 0.59
Under $20,000 14 40 54 26 24 14 38 63
$20,000 to < $40,000 9 21 30 30 16 4 20 80
$40,000 to < $60,000 6 14 20 30 10 7 17 59
$60,000 to < $80,000 1 5 6 17 3 2 5 60
$80,000 or more 2 2 4 50 2 1 3 67
Health insurance 0.89 0.41
No 2 6 8 25 5 3 8 63
Yes 31 80 111 28 54 26 80 68
Family education 0.96 0.41
Completed 9th or less 1 3 4 25 2 2 4 33
Completed 10th or 11th 47 1 13 6 448 5 0
Graduated High School 14 30 44 32 23 8 31 74
Post high school work 10 36 46 22 23 11 34 68
Graduated college 4 12 16 25 9 4 13 69
Household size 0.20 0.89
21 3 4 4 5 7 2 3 2 8 1 7 4 5 6 2
31 2 4 7 5 9 2 0 2 7 1 1 3 8 7 1
4 6 16 22 27 16 1 17 94
5+ 8 11 19 42 7 6 13 54
* p-values are reported from repeated-measures logistic regression to account for within family correlation. All p-values test for the significance of 
the characteristic after adjusting for age, in both children and adults, and the quadratic trend in age for children.
+ Pos = CMV seropositive. Neg. = CMV seronegative. %Pos = the percentage of all test results that were positive.BMC Infectious Diseases 2008, 8:107 http://www.biomedcentral.com/1471-2334/8/107
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cans for the entire US, the average rate of seropositivity for
African-American adults was 75.8% [4]. All of the pub-
lished adult data were obtained in the late 1980s and early
1990s. A study conducted in the late 1980s in Houston
reported infection rates for African-Americans between 6
and 22 years of age which increased with age from 30% to
75% [2]. Similarly, in the US population-based study,
infection rates for African-Americans tested between 1988
and 1994 from 6 to 20 years of age ranged from 40% to
65% [4]. These rates are similar to those we observed for
the current generation of adult females.
Ours is the first recent study to determine CMV seroprev-
alence rates for the current generation of lower socioeco-
nomic African American children and adolescents. We did
not measure the seroprevalence rates in age-matched Cau-
casians. However, the low rates we observed for lower
socioeconomic African American children and adoles-
cents were nearly identical to the low seroprevalence rates
reported for Caucasians children and adolescents meas-
ured for the entire US population between 1988 and 1994
and for Caucasian children measured in Houston Texas in
the late 1980s [2,4]. In contrast, in these studies the sero-
prevalence rates for African-American children were sig-
nificantly higher than age-matched Caucasians. Thus our
data suggest the current generation of African-American
and Caucasian children will have similar CMV seropreva-
lence rates.
Our observations may be explained by two factors. First,
our subject sample may not be representative of the pop-
ulation of African-Americans residing in Richmond, VA or
elsewhere especially since we selected subjects seeking
medical consultation. This seems unlikely for two rea-
sons. As discussed above, we observed seroprevalence
rates for the adults who were predominantly female
which were similar to those previously reported for Rich-
mond and other US cities [1-6]. Second, our population
was similar in demographic characteristics to that
described by the US census for African-Americans in resid-
ing the City of Richmond, the state of Virginia, and the
nation.
A second more likely reason we observed a lower rate of
seroprevalence among African-American children may
relate to the infrequent sexual activity reported by our
adolescents. The preadolescent seroprevalence rates we
observed were similar to those reported in the Houston
study (30%–40%) and in the population-based US study
(40%) [2-4]. However, in both these studies there was a
marked increase in infections rates among adolescents.
Sexual activity during adolescence has been frequently
associated with increased rates of CMV infection [6,7,10].
Hence our results suggest a decrease in CMV infection in
the current generation of African-Americans may have
occurred due to decreased sexual activity, increased con-
dom use, or a reduced number of sexual partners during
adolescence. AIDS awareness may in part be responsible
for this and it will be important to determine if similar
changes in sexual behavior and CMV infection rates is also
Relationship between age and the rate of CMV seropositivity  for 103 adults and 157 children Figure 1
Relationship between age and the rate of CMV seropositivity 
for 103 adults and 157 children. 95% confidence intervals.
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Table 2: The Association of CMV Status between 104 Mothers and their Children.
Mothers
Household children CMV positive CMV negative Total tested Per cent positive
Number CMV positive 30 24 54 55*
Number CMV negative 50 36 86 58
*Not significantly different from the rate of seronegative children, Fisher's exact p-value = 0.86BMC Infectious Diseases 2008, 8:107 http://www.biomedcentral.com/1471-2334/8/107
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occurring among lower socioeconomic African-American
children and adolescents in other cities.
Other factors such the number of children per household
and/or changes in hygienic practices may also account for
the reduced rate of CMV seroprevalence infections we
observed in the current generation of African-American
adolescents and children as compared to the higher rates
observed in their parents and in older studies.
We observed a decline in the seropositivity rate with age
for African-American adults between 40 and 45 years of
age. The significance, if any, of this observation is uncer-
tain This decline was not due to reduced antibody levels
in saliva associated with aging since antibody titers to
CMV persist for life and actually increased throughout
adulthood with highest levels in the elderly [11].
Although this decline may represent another cohort of
older African-Americans with lower infection rates, the
number of subjects in this age range was low and thus the
95% confidence intervals were wide and as shown in fig-
ure 1, the 95% confidence intervals overlapped.
The second novel observation from our study was that sib-
ling-to-sibling transmission may have been the primary
mode of CMV acquisition among African-American chil-
dren and adolescents. This was very different than we pre-
viously observed among Caucasian children in day care
[12]. For those Caucasian children, child-to-child trans-
mission of CMV acquired in day care was very common
but sibling-to-sibling transmission at home seldom
occurred. In the current study only 19 children reported
day care attendance. Children not in day care probably
spend more time at home with their siblings than occurs
for children attending day care. Since child-to child trans-
mission of CMV requires prolonged and frequent contact;
the association of seroprevalence rates among African-
American siblings, most of whom received home care,
may represent sibling-to sibling transmission.
In our study 91% per cent of the caregivers were the bio-
logical mothers and over 70% were seropositive. Thus our
data further indicate CMV acquisition by children from
maternal sources such cervical-vaginal secretions, breast
milk, or saliva is unlikely to account for the high rate of
CMV infections among African- American adults. If infec-
tion from maternal sources occurred frequently, the chil-
dren we observed should have had high CMV
seroprevalence rates.
Conclusion
We observed that the current generation of African-Amer-
ican children had CMV seroprevalence rates by age 20
years of less than one-half of that of their mothers. Our
Table 3: The Association of CMV Status between Index Children and their Siblings+.
Index children
Household siblings Number CMV positive Number CMV negative Total tested Per cent positive
Number CMV positive 8 2 10 80*
Number CMV negative 1 26 27 3
+From 30 families.
*Significantly different from the rate of seronegative siblings, Fisher's exact p-value < 0.0001.
Table 4: Comparison of Study Subjects to African-Americans Locally, State-wide, and Nationally.
Group
Characteristic Study subjects City of Richmond * Virginia (entire state)* US population*
Average number of persons/household 2.9 2.5 2.7 3.0
Median household income $29,000 $25,292 $32,080 $29,423
Per cent of female children 51.6 51.5 49.8 49.3
Percent of Household adults by education level
< 9th grade 1 5 5 8
9th to 12th grade 13 24 19 12
High school or equivalency 39 34 32 29
Some college or associate degree 34 27 30 27
Bachelor's or postgraduate degree 13 10 14 24
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data suggest that sibling-to-sibling transmission was a
possible source of CMV infections for the children. If our
observations for Richmond VA represent what has
occurred nationwide, a large proportion of the next gener-
ation of African-American women will be susceptible to a
primary CMV infection during pregnancy and will benefit
from a CMV vaccine. Exposure to household children is a
major risk factor for congenital CMV infection [10]. Since
we observed that 92% of infants are seronegative, infant
immunization may be optimal.
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